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Introduction   
Ancylostomatids	 are	 some	 of	 the	 most	
important	parasites	affecting	dogs	worldwide,	 in	
terms	of	diffusion	and	risk	for	animal	and	human	
health	(Traversa,	2012;	Wright,	2009).	
They	are	also	pathogenic	in	humans,	causing	
cutaneous	 larva	 migrans	 (CLM)	 or	 creeping	
eruption	and	eosinophilic	enteritis	 (Brenner	and	
Patel,	2003;	Croese	et al.,	1994).	
Infective	 stages	 are	 either	 ingested	 by	 the	
definitive	host	as	free-living	third-stage	larvae,	L3,	
lactogenically,	or	via	paratenic	hosts.	However,	the	
L3	also	are	able	to	penetrate	percutaneously	after	
complex	neurohormonal	actions	that	are	triggered	
by	skin	conditions	(Epe,	2009). Most	pet	owners	
do	 not	 follow	 the	 manufacturers	 and	 doctors	
recommendations,	 deworming	 at	 irregular	 and	
consequently	 ineffective	 intervals	 (Cernea	 et al., 
2010;	Matos	et al.,	2015).	In	the	past	few	years	the	
scientific community’s attention	has	been	attracted	
by	 feline	 and	 canine	 extra-intestinal	 parasitic	
nematodes.	This	change	led	to	the	misconception	
that	 intestinal	 worms	 of	 cats	 and	 dogs	 do	 not	
deserve	a	high-standard	level	of	attention	anymore	
(Traversa,	2012;	Robertson and Thompson, 2002). 
These	 problems	 occur	 worldwide,	 both	 in	 rural	
and	 urban	 areas.	 Drug	 resistance,	 defined	 by	
WHO	 as	 the	 ability	 of	 parasites	 in	 a	 population	
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Abstract: 
The	study	was	conducted	using	faecal	samples	from	62	dogs.	We	tested	the	ovicidal	and	larvicidal	effects	of	
albendazole	(ABZ),	mebendazole	(MBZ),	fenbendazole	(FBZ)	and	flubendazole (FLU)	by	Egg	hatch	assay	(EHA)	and	
larval	development	assay	(LDA).	For	pyrantel	(PYR)	and	selamectin	(SEL)	we	tested	the larvicidal	effects	by	LDA.	
In	all	in vitro	tests,	benzimidazoles	efficacy	was	low,	with	a	high	risk	of	inducing	resistance	phenomena.	In	EHA	
more	than	50%	of	the	hookworm	eggs	hatched,	revealing	a	low	efficacy	of	all	tested	benzimidazoles.	The	regression	
line	was	positive	for	all	benzimidazoles,	FBZ	having	the	smallest	value	of	the	Y	parameter	(62.62),	and	lower	risk	
of	resistance.	When	testing	the	larvicidal	effects,	a	superior	efficacy	of	benzimidazoles	was	observed.	The	lowest	
MIC	was	for	MBZ	(0.8672µg/ml).	ABZ	had	a	very	poor	effect	(8.46750	µg/ml).	The	Y	parameter	showed	a	lower	
risk	of	inducing	resistance	for	MBZ	(Y=	-64.14)	and	FBZ	(Y=	-27.89).	Pyrantel	and	Selamectin	were	very	effective,	
presenting	also	a	very	low	risk	of	inducing	resistance	phenomena.	For	PYR	and	SEL,	MIC	was	0.2131	µg/ml	and	
2.7921	µg/ml,	respectively.	The	Y	parameter	was	-448.37	for	PYR	and	-62.74	for	SEL,	with	minimal	risk	of	inducing	
the	adaptive	phenomena.	
Keywords:  Ancylostomatidae,	benzimidazoles,	dog	hookworms,	EHA,	LDA,	Pyrantel,	Selamectin
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to	 survive	 drug	 treatment,	 which	 is	 generally	
effective	 against	 the	 same	 species	 at	 the	 same	
stage	 of	 infestation	 at	 an	 identical	 dosage	 level	
(World	 Health	 Organization,	 2011)	 has	 become	
comonly	 reported.	 One	 of	 the	 biggest	 concern	 is	
the	resistance	against	benzimidazole	compounds	
(Cernea	 et al., 2010),	 associated,	 for	 example,	 to	
single	nucleotide	polymorphisms	in	the	β-tubulin	
isotype	1	gene	(VianaFurtado	et al.,	2014).	 
The	 present	 paper	 aims	was	 to	 evaluate	 the	
efficacy	 of	 selected	 members	 of	 benzimidazole,	
tetrahydropyrimidine	 and	 macrocyclic	 lactone	
anthelmintics	groups	against	canine	hookworms.
Materials and methods 
In	 order	 to	 test	 in vitro	 the	 efficacy	 of	
anthelmintic	 substances	 used	 for	 the	 treatment	
of	hookworms,	we	conducted	a	study	on	62	dogs	
living	 in	 rural	 regions	 of	 Cluj	 County,	 between	
March	and	December	2017.	We	tested	in vitro	the	
ovicidal	and	larvicidal	effects	of	four	benzimidazole	
compounds:	 albendazole	 (ABZ),	 mebendazole	
(MBZ),	 fenbendazole	 (FBZ)	 and	 flubendazole 
(FLU).	 We	 also	 tested	 the	 larvicidal	 effects	 of	
pyrantel	 (PYR)	 from	tetrahydropyrimidine	group	
as	 well	 as	 selamectin	 (SEL)	 from	 macrocyclic	
lactone	group.	The	 in vitro	 tests	were	performed	
by	 using	 Egg	 Hatch	 Assay	 (EHA)	 and	 Larval	
Development	Assay	(LDA).	From	each	 individual,	
fresh	 faecal	 samples	were	 collected	 and	 a	mixed	
sample	was	obtained.	The	Ancylostomatidae	eggs	
were	collected	from	this	mixed	sample	by	flotation	
methods.	The	techniques	were	performed	within	
the	Pharmacovigilance	Laboratory	of	Cluj-Napoca	
Veterinary	Medicine	Faculty	as	per	protocol	of		Le	
Jambre	(1978).	
The	 total	 number	 of	 eggs	 per	 milliliter	 was	
determined	by	using	the	formula:	
Eggs/ml = (1000 x no. eggs per 50µl) / 50
We	used	EHA	 in	order	 to	assess	 the	ovicidal	
properties	 of	 the	 benzimidazole	 compounds:	
albendazole	 (ABZ),	 mebendazole	 (MBZ),	
fenbendazole	 (FBZ)	 and	 flubendazole	 (FLU).	 For	
each	 active	 drug,	 serial	 mother	 solutions	 were	
obtained,	ranging	from	500	mcg	to	0.98	mcg	active	
drug/ml.	 The	 samples	 were	 placed	 in	 2	ml	 well	
plates.	For	each	compound,	10	wells	of	successively	
diluted	 active	 drugs	 were	 used,	 containing	 790	
μl	 of	 distilled	 water,	 200	 µl	 of	 egg	 suspension,	
containing	 about	 500	 parasite	 eggs,	 and	 10	 µl	
diluted	 active	 drug	 solutions.	 The	 final	 testing	
solutions	had	active	drug	concentrations	ranging	
from	5.0	to	0.0098	mcg/ml.	Two	negative	controls	
were	used,	M
1
	consisting	of	200	µl	egg	suspension,	
containing	 about	 500	 parasite	 eggs,	 and	 800	 µl	
distilled	water	and	M
2
	consisting	of	790µl	distilled	
water,	200	µl	egg	suspension,	containing	about	500	
parasite	eggs,	 	and	10	µl	of	HCl	solution.	The	M2	
control	was	used	only	for	testing	benzimidazoles,	
because	of	the	fact	that	these	active	drugs,	have	to	
be	 dissolved	 in	 hydrochloric	 acid	 before	 mixing	
them	with	water.
The	 samples	were	 kept	 in	 the	 thermostat	 at	
27ºC	 for	 24	hours	 and	 assessed	by	 counting	 the	
embryonated and unembryonated	 eggs	as	well	as	
the	hatched	 larvae.	The	 egg	hatching	percentage	
was	determined	applying	the	formula:
Egg hatching % = [(EE + L1 ) / ( UE + EE + L1)] x 100
(Le	Jambre	et al.,	1978,	Coles	et al.,	1992),	where	
EE	signifies	the	embryonated	eggs,	L
1
	represents	
larvae	L
1
	and	UE	signifies	unembryonated	eggs.
Larval	development	assay	(LDA)	was	used	to	
test	larvicidal	effects	of	albendazole	(ABZ),	meben-
dazole	 (MBZ),	 fenbendazole	 (FBZ),	 flubendazole 
(FLU),	pyrantel	 (PYR)	 and	 selamectin	 (SEL).	The	
dilution	 protocol	 was	 identical	 to	 the	 one	 used	
for	 EHA,	 and	 the	 final	 testing	 solutions	 had	 the	
same	 active	 drug	 concentrations	 ranging	 from	
5.0	 to	 0.0098	 mcg/ml.	 The	 test	 had	 a	 duration	
of	14	days	in	order	to	culture	eggs	trough	the	L3	
stage.Samples	were	kept	in	thermostat	at	27ºC	for	
14	 days.	 For	 this	 assay	 the	 minimum	 inhibitory	
concentration	 (MIC)	was	obtained	by	 calculating	
the	 larval	 development	 percentage,	 applying	 the	
formula:	
Larval development % = [(L3  / ( UE + L3)] x 100
where	 L
3
	 represents	 the	 number	 of	 L
3
	 larvae	
and	UE	stands	 for	unembryonated	eggs,	as	per	
protocole	of	Coles	et al.	(1988).
The	obtained	 results	were	 statistically	 inter-
preted	 using	 Anthelmintic	 Resistance	 Program	
(ARP™),	 a	 PC	 software	 created	 especially	 for	 this	
type	of	calculations.	ARP	calculates	and	correlates	
the	following	parameters:	egg	hatching	percentage,	
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larval	 development	 percentage,	 regression	 line	
and	 and	 its	 equation	 (Y	 parameters),	 EC
50
	 (the	
mean	 concentration	 that	 inhibits	 hatching	 in	
50%	 of	 eggs)	 and	 MIC	 (minimum	 inhibitory	
concentration).	Interpretation	of	EHA	results	was	
obtained	 by	 comparing	 them	 to	 those	 obtained	
at	 a	 reference	 concentration	 of	 0.15	 mcg/ml,	
as	 parasite populations	 in	which	 eggs	hatch	 in	 a	
percentage	of	50	or	above	are	considered	resistant	
(Cernea	et al.,	2010,	Coles	et al.,	1992).
Results and discussions   
In	EHA,	for	ABZ	high	hatching	percentages	were	
found	 in	 all	 used	 concentrations.	 The	 minimum	
value	was	recorded	at	5	mcg/ml	concentration,	for	
which	 the	 egg	 hatching	 percentage	was	 14.29%.	
Consequently,	the	a	parameter	value	was	-7.1	and	
the	b	parameter	102.13,	determining	a	positive	Y	
max	value	(66.63)	(Table	1).
As	a	result,	the	efficacy	of	ABZ	on	Ancylostoma-
tidae	 eggs	 is	 low,	 this	 being	 also	 highlighted	 by	
the	 high	 value	 of	 EC
50
	 (7.33450	mcg/ml).	 The	 Y	
parameter	values	determined	for	all	concentrations	
used	in	ABZ,	revealed	a	slightly	negative	trend	of	
the	 regression	 line,	 which	 indicates	 an	 average	
risk	 of	 installing	 adaptive	 phenomena.	 At	 the	
reference	 concentration	 of	 0.15	 mcg/ml,	 Egg	
hatching	percentage	was	101.07%,	well	above	the	
maximum	limit	considered	as	resistance	threshold	
(50%)	(Table	1).
A	similar	situation	was	also	revealed	 in	MBZ	
testing.	 The	 minimum	 egg	 hatching	 percentage	
was	 recorded	 at	 5	 mcg/ml	 concentration	
(59.52%),	while	at	reference	concentration,	it	was	
100.43%,	 showing	 thet	MBZ	had	 limited	efficacy	
on	the	studied	helminths.	EC
50	
doubled	compared	
to	the	one	obtained	for	ABZ	(15.189	mcg/ml).	The	
regression	line	 	had	a	slightly	negative	trend,	the	
value	of	Y	max.	parameter	being	84.18	(Table	1).	
The	results	obtained	with	FBZ	 in	 the	case	of	
EHA	 have	 highlighted	 a	 situation	 similar	 to	 that	
found	in	ABZ	and	MBZ.	The	egg	hatching	percentage	
Table 1.	EHA	results	for	the	tested	benzimidazoles
A.i.	conc.
(mcg
/ml)
ABZ MBZ FBZ FLU
Egg	
hatching	
%
Regression	
line	equation
Egg	
hatching	%
Regression	
line	
equation
Egg	
hatching	%
Regression	
line	equation
Egg	
hatching	%
Regression	
line	equation
5.0000 14.29 66.63 59.52 84.18 46.67 62.62 77.78 88.08
2.5000 50.00 84.38 83.33 92.56 66.67 81.57 77.78 94.28
1.2500 100.00 93.26 96.00 96.74 75.00 91.05 100.00 97.38
0.6250 100.00 97.69 100.00 98.84 100.00 95.78 100.00 98.93
0.3125 100.00 99.91 100.00 99.88 100.00 98.15 100.00 99.71
0.1563 100.00 101.02 100.00 100,41 100.00 99.34 100.00 100.09
0.0781 100.00 101.58 100.00 100.67 100.00 99.93 100.00 100.29
0.0391 100.00 101.85 100.00 100.80 100.00 100.22 100.00 100.38
0.0195 100.00 101.99 100.00 100.86 100.00 100.37 100.00 100.43
0.0098 100.00 102.06 100.00 100.90 100.00 100.45 100.00 100.46
0.0	(M1) 100.00 102.13 100.00 100.93 100.00 100.52 100.00 100.48
0.0	(M2) 100.00 0.00 100.00 0.00 100.00 0.00 100.00 0.00
Parameters Parameters Parameters Parameters
a -7.1 a -3.35 a -7.58 a -2.48
b 102.13 b 100.93 b 100.52 b 100.48
Hatching	
%	ref
101.07
Hatching	
%	ref.
100.43
Hatching	
%	ref.
99.38
Hatching	
%	ref.
100.11EC
50
7.33450 EC
50
15.18920 EC
50
6.66240 EC
50
20.28040
Note:	A.i.	conc.	=	active	drug	concentration,		EC
50
=	mean	concentrations	that	inhibited	hatching	in	50%	of	the	eggs,	Hatching	%	ref.	=		
Hatching	percentage	at	reference	concentration	of	0.15	mcg/ml
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at	 reference	 concentration	 being	 99.38%,	 with	
EC50	 6.66240	 mcg/ml.	 The	 maximum	 value	 of	
Y	 parameter	 was	 62.62,	 which	 implied	 a	 slight	
negative	trend	for	the	regression	line	(Table	1).
The	 FLU	 testing	 for	 Ancylostomatidae eggs, 
revealed	the	worst	efficacy	compared	to	the	other	
benzimidazoles.	 The	 egg	 hatching	 percentage	 at	
reference	 concentration	was	 100.11%,	with	 EC
50
 
20.2804	mcg/ml.	 As	 a	 result	 the	 regression	 line	
tendency	 ranged	 between	 88.08	 and	 100	 (Table	
1).
LDA	 testing	 of	 the	 benzimidazoles	 revealed	
improved	 efficacy	 compared	 to	EHA	 tests.	 These	
results	are	due	to	the	longer	contact	time	between	
anthelmintic	 substances	 and	 parasitic	 forms,	
benzimidazoles	having	both	ovicidal	and	larvicidal	
actions	(Cernea	et al.,	2010).
In	 ABZ	 testing	 by	 LDA,	 the	 percentage	 of	
larval	 development	 inhibition	 varied	 according	
to	the	active	drug	concentration,	being	maximum	
at	 2.5	 mcg/ml,	 respectively	 0.625	 mcg/ml	 (0%)	
concentrations.	 Minimal	 percentage	 of	 larval	
development	 inhibition	 was	 recorded	 at	 the	
concentrations	 of	 0.0781	 mcg/ml,	 respectively	
0.0098	 mcg/ml	 (100%).	 The	 trend	 of	 the	
regression	line,	influenced	by	Y	parameter	values,	
was	 negative,	 the	 maximum	 being	 33.16.	 MIC	
when	 tested	by	using	 the	ARP	programe	a	had	a	
value	of	8.4675	mcg/ml	(Table	2).	
In	the	case	of	MBZ	testing	by	LDA,	the	results	
obtained	 are	 much	 better	 compared	 to	 those	
obtained	at	EHA.	It	is	noted	that	the	prolongation	
of	 the	 contact	 time	 between	parasitic	 forms	 and	
MBZ	 determines	 its	 high	 efficacy.	 The	 larval	
development	inhibition	percentage	at	the	minimal	
concentration	(0.0098	mcg/ml)	was	12.50%.	The	
effectiveness	 of	 MBZ	 is	 also	 highlighted	 by	 the	
low	 MIC,	 which	 is	 0.86720	 mcg/ml.	 Due	 to	 the	
high	efficacy	of	MBZ,	 the	regression	 line	 trend	 is	
negative,	the	value	of	the	Y	max.	parameter	being	
-64.14	(Table	3).	
Improvement	 of	 anthelmintic	 efficacy	 was	
also	 noted	 in	 the	 case	 of	 FBZ,	 the	 MIC	 being	
of	 1.9630	 mcg/ml.	 Larvae	 development	 was	
completely	 inhibited	 at	 concentrations	 between	
5	 and	 1.25	 mcg/ml,	 respectively	 0.1563	 mcg/
CĂTANĂ et al
Table 2.	LDA	results	for	the	tested	benzimidazoles
A.i.	conc.
(mcg/ml)
ABZ MBZ FBZ FLU
Larval	
development	
%
Regression	
line	
equation
Larval	
development	
%
Regression	
line	
equation
Larval	
development	
%
Regression	
line	
equation
Larval	
development	
%
Regression	
line	
equation
5.0000 14.29 33.16 14.29 -64.14 0.00 -27.89 28.00 -1.96
2.5000 0.00 53.41 20.00 -22.32 0.00 -4.42 50.00 28.42
1.2500 50.00 63.54 25.00 -1.40 0.00 7.32 46.67 43.60
0.6250 0.00 68.60 33.33 9.05 10.00 13.19 0.00 51.20
0.3125 42.86 71.13 25.00 14.28 7.14 16.13 27.27 54.99
0.1563 73.33 72.39 20.00 16.90 0.00 17.59 33.33 56.89
0.0781 100.00 73.03 16.67 18.20 10.00 18.33 57.14 57.84
0.0391 71.43 73.34 16.67 18.86 33.33 18.69 66.67 58.31
0.0195 72.73 73.50 16.67 19.18 33.33 18.88 90.00 58.55
0.0098 100.00 73.58 12.50 19.35 14.29 18.97 62.50 58.67
0.0 (M1) 10.00 73.66 10.00 19.51 10.00 19.06 10.00 58.79
0.0 (M2) 60.00 73.66 20.00 19.51 20.00 19.06 60.00 58.79
MIC	(mcg/ml) MIC	(mcg/ml) MIC	(mcg/ml) MIC	(mcg/ml)
8.46750 0.86720 1.96300 4.42720
Parameters Parameters Parameters Parameters
a
b
-8.1 a -16.73 a -9.39 a -12.15
73.66 b 19.51 b 19.06 b 58.79
Note:	A.i.	conc.	=	active	drug	concentration,	MIC	=	Minimum	inhibitory	concentration
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ml.	Maximum	percentages	of	 larval	development	
(33,33%),	were	recorded	at	lower	concentrations	
(0.0391	and	0.0195	mcg/ml).	The	negative	value	
of	a	parameter	 (-9,39),	 influenced	 the	value	of	Y,	
that	had	a	maximum	of	-27.89.	Due	to	these	values,	
the	regression	line	tendency	is	negative	(Table	2).
In	 the	 LDA	 tests,	 FLU	 presented	 the	 lowest	
efficacy.	The	complete	inhibition	of	L3	was	noted	
only	at	 the	concentration	of	0.6250	mcg/ml.	The	
maximum	 value	 of	 development	 percentage	
(90%),	was	 recorded	 at	 concentration	 of	 0.0195	
mcg/ml.	 The	 maximum	 value	 of	 Y	 parameter	
was	 -1.96,	 and	MIC	 4.4272	mcg/ml.	 As	 a	 result,	
although	 the	 trend	 of	 the	 regression	 line	 was	
negative,	we	can	assume	 that	 in	 the	case	of	FLU,	
the	 parasites	 from	 Ancylostomatidae family	 are	
susceptible	to	resistance	(Table	2).
The	best	results	for	the	LDA	tests,	respectively	
the	highest	efficacy,	were	obtained	 in	 the	case	of	
PYR.	The	larval	development	inhibition	percentage	
was	maximal	at	concentrations	of	5,	0.3125,	0.1563	
and	0.0391	mcg/ml,	determining	the	calculation	of	
a	0.2131	mcg/ml	MIC.	Compared	with	other	tested	
active	drugs,	due	to	the	values	of	the	parameters	
a	 and	 b,	 Y	max	 parameter	 had	 the	 lowest	 value	
(-448.37).	 Consequently,	 the	 regression	 line	 had	
a	strong	negative	trend,	which	reveals	a	 low	risk	
of	resistance	of	the	studied	parasites	to	PYR-based	
anthelmintics	(Table	3).
SEL	 completely	 inhibited	 the	 development	
of	L3	 larvae	at	 concentrations	 ranging	 from	5	 to	
0.3125	 mcg/ml	 and	 MIC	 was	 2.7921	 mcg/ml.	
These	data	show	the	good	efficacy	of	SEL	against	
parasites	from	Ancylostomatidae	family,	but	lower	
compared	 to	 PYR.	 The	 regression	 line	 equation	
recorded	for	the	Y	max.	parameter	a	higher	value	
than	for	PYR	(-62.74).
The	 risk	 analysis	 of	 adaptive	 phenomena	
emergence	for	Ancylostomatidae	family	helminths,	
determined	 by	 the	 EHA	 test,	 reveals	 that	 for	 all	
tested	 benzimidazole	 compounds	 Y	 parameter	
values	are	with	a	positive	trend	between	62.62	and	
88.08.	 As	 a	 result,	 for	 these	 active	 drugs	 of	 the	
benzimidazoles	family	there	is	a	significant	risk	of	
resistance	for	the	isolated	parasitic	forms.
The	 results	 are	 different	 in	 the	 LDA	 test,	
where	Y	parameter	values	were	negative	for	MBZ	
(Y=	 -64.14),	 FBZ	 (Y=-27.89),	 FLU	 (Y=-1.96),	 PYR	
(Y=-448.37)	şi	SEL	(Y=-62.64).	Only	ABZ	has	been	
found	to	have	a	positive	Y	max	value	(33.16),	which	
impressed	a	trend	towards	+	∞	for	the	regression	
line.	 Interpretation	 of	 these	 values	 highlights	
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Table 3.	LDA	results	for	pyrantel	and	selamectin
A.i.	conc.
(mcg/ml)
PYR SEL
Larval	
development	%
Regression	line	
equation
Larval	
development	%
Regression	line	
equation
5.0000 0 -448.37 0.00 -62.74
2.5000 10 -212.90 0.00 -31.27
1.2500 10 -95.16 0.00 -15.53
0.6250 10 -36.29 0.00 -7.66
0.3125 0 -6.85 0.00 -3.72
0.1563 0 7.86 12.50 -1.76
0.0781 20 15.22 25.00 -0.77
0.0391 0 18.90 40.00 -0.28
0.0195 20 20.74 66.67 -0.04
0.0098 60 21.66 50.00 0.09
0.0000	(M1) 20 22.58 10.00 0.21
Parameters Parameters
a -94.19 MIC	-	mcg/ml a -12.59 MIC	-	mcg/ml
b 22.58 0.21310 b 0.21 2.79210
Note: A.i. conc. = active drug concentration, MIC = Minimum inhibitory concentration
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the	 fact	 that	 the	 studied	 parasitic	 population	 is	
highly	susceptible	for	emergence	of	ABZ-resistant	
individuals.	
The	active	drugs	with	the	lowest	susceptibility	
to	 inducing	 resistance were	 MBZ,	 PYR	 and	 SEL.	
Improvement	 in	 anthelmintic	 efficacy	 has	 also	
been	noted	in	FBZ,	MIC	being	1.9630	mcg/ml	and	
larvae	 development	 being	 completely	 inhibited	
at	 concentrations	 between	 5	 and	 1.25	 mcg/ml,	
respectively	0.1563	mcg/ml.	
The	regression	lines	obtained	in	EHA	and	LDA	
tests,	correlate	with	EC
50	
and MIC	values.	EC50	with	
the	 lowest	 value	was	 obtained	 for	 the	 EHA	with	
FBZ	(6.6624	mcg/ml).	From	this	point	of	view,	the	
lowest	 efficacy	 was	 recorded	 for	 FLU	 (20.2804	
mcg/ml)	and	MBZ	(15.1892	mcg/ml).
For	PYR	test,	a	concentration	of	0.2131	mcg/
ml	 was	 sufficient	 to	 completely	 inhibit	 larval	
development	 in	 LDA	 test.	 For	 SEL	 the	 MIC	 was 
2.7921	mcg/ml.	For	the	benzimidazole	compounds	
the	lowest	MIC	values	were	noted	at	MBZ	(0.8672	
mcg/ml). 
Due	to	the	fact	that	active	drugs	with	different	
action	 mechanisms	 have	 different	 MIC,	 it	 is	 not	
correct	to	compare	the	efficacy	of	these	substances	
with	the	resulting	MIC.	Comparisons	can	only	be	
made	by	correlations	between	EC50,	MIC	and	the	
regression	line	trend.	
As	 a	 result,	 taking	 into	 account	 the	 three	
elements,	 the	 highest	 efficacy	 and	 the	minimum	
risk	of	adaptive	phenomena	induction	for	the	tested	
parasites from	 the Ancylostomatidae	 family are	
PYR,	SEL,	MBZ,		and	FBZ.	ABZ	is	not	recommended	
to	be	used	for	hookworm	treatments	in	the	animals	
used	in	the	study.	
The	benzimidazoles	pharmacological	activity	
is	based	on	the	binding	to	parasite	β-tubulin,	which	
produces	 subsequent	 disruption	 of	 the	 tubulin–
microtubule	 dynamic	 equilibrium.	 Additionally,	
the	 inhibition	 of	 secretion	 of	 nematode	
acetylcholinesterase	 and	 inhibition	 of	 some	
enzymatic	activities	(such	as	fumarate	reductase,	
malate	 dehydrogenase,	 phosphoenol	 pyruvate	
reductase,	 and	 succinate	 dehydrogenase)	 have	
been	associated	with	the	BZD	anthelmintic	action	
(Lacey,	1990;	Riviere	and	Papich,	2018).	The	fact	
that	 the	 benzimidazoles	 compounds	 presented	
improved	 efficacy	 if	 the	 parasitic	 forms	 are	 kept	
longer	time	in	contact	with	the	active	ingredients	
is	due	to	their	ovicidal	and	larvicidal	actions,	being	
stated	 also	 by	 other	 researches	 (Cernea	 et al., 
2010,	Cristina,	1997).	
For	 albendazole,	 due	 to	 intense	 liver	
metabolism	 and	 transformation	 into	 active	
metabolites,	 with	 the	 involvement	 of	 the	
cytochrome	 P450	 and	 flavin	 monooxygenase	
systems,	efficacy	can	be	much	greater	when	tested	
in vivo	 compared	 to	 in vitro	 (Cernea	et al.,	2010;	
Riviere	and	Papich,	2018).		
Selamectin	 action	 mechanism	 against	
nematodes	 is	 by	 inducing	 paralytic	 effects	 on	
the	 parasite	 somatic	 musculature	 and	 on	 the	
pharyngeal	pump	which	affects	nutrients	ingestion.	
The	paralytic	effects	are	mediated	through	GABA	
and	glutamate-gated	chloride	channels.	They	are	
considered	as	extremely	effective	against	adult	and	
larval	 stages	 of	most	 gastrointestinal	 nematodes	
(Riviere	and	Papich,	2018).	
Selamectin	 eficacy	 against	 hookworms	 is	
mentioned	 in	 various	 research	 in	 the	 field	 of	
parasitology,	 being	 considered	 as	 a	 very	 good	
antiparasitic	 molecule	 both	 for	 dogs	 and	 cats	
(Bishop et al., 2000; McTier	et al.,	2000;	Geurden	
et al.,	2017).	
In	 the	 case	 of	 macrocyclic	 lactones	 treat-
ments,	 the	 risk	 of	 treating	 MDR1	 genetically	
defective	dogs	should	also	be	taken	into	account. 
Selamectin	 use	 is	 considered	 safe	 in	 ivermectin	
sensitive	 Collie	 dogs	 (Riviere	 and	 Papich,	 2018).	
Changes	in	the	glutamategated	chloride	channels	
structure	and	an	increased	expression	of	different	
proteins	involved	in	drug	efflux	(P-GP)	have	been	
postulated	 as	 the	main	mechanism	 of	 resistance	
to	 macrocyclic	 lactones	 in	 nematodes	 (Riviere	
and	Papich,	2018).In	our	research,	 for	 the	 tested	
parasites, we	found	no	risk	in	inducing	addaptative	
phenomena	against	this	active	drug.			
The	larvicidal	effects	of	tetrahydropyrimidine	
compounds	 are	 due	 to	 their	 selective	 action	 as	
agonists	 at	 synaptic	 and	 extrasynaptic	 nicotinic	
acetylcholine	 receptors	 (nAChR)	 on	 nematode	
muscle	 cells.	 They	 produce	 contractions	 and	
spastic	 paralysis,	mimicking	 the	 paralytic	 effects	
of	 excessive	 acetylcholine	 amounts.	 Pyrantel	 is	
poorly	 absorbed	 from	 the	 GI	 tract.	 The	 drug	 is	
considered	 to	 be	 highly	 effective	 against	mature	
worms	 and	 larval	 stages	 (Cernea	 et al.,	 2015;	
Riviere	and	Papich,	2018).	
Drug	 combinations	 are	 often	 recommended	
for	 their	 better	 efficacy	 and	 for	 lowering	 the	
risks	 of	 resistance	 phenomena,	 often	 we	 see	
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recomendations	of	macrocyclic	lactones,	pyrantel	
and	fenbendazole	(Wright,	2009;	Miro	et al.,	2007;	 
Clark et al., 1992; Shoop et al., 1996).	
On	the	other	hand,	empirical	use	anthelmintics,	
without	 consulting	 the	 veterinarian,	 may	 lead	
in	 the	 near	 future	 to	 the	 emergence	 of	 resistant	
strains	 that	 will	 complicate	 the	 therapeutic	
protocol,	 increase	 the	 risk	 of	 dissemination,	 and	
consequently	 increase	 the	 number	 of	 infected	
animals	and	even	people,	as	these	ancylostomatids	
worms	 show	 zoonotic	 potential (Brenner	 and	
Patel,	2003;	Croese	et al.,	1994).	
This	type	of	efficacy	and	resistance	prediction	
tests	 are	 recommended	 to	be	performed	at	 least	
once	a	year	due	to	the	ability	of	parasites	to	adapt	
to	drug	therapy	in	a	relatively	short	time.
Conclusions   
Ovicidal	effects	of	benzimidazole	group	subs-
tances	was	low,	indicating	the	resistance	potential	
of	 hookworms	 to	 these	 substances	 is	 very	 high	
except	for	FBZ,	with	lower	resistance	risk.
The	larvicidal	effects	of	benzimidazole	group	
substances,	were	better	compared	to	the	ovicidal	
effects,	with	the	exception	of	albendazole.	
The	 risk	 of	 inducing	 resistance	 phenomena	
against	 bezimidazole	 compounds	 proved	 to	 be	
lower	if	the	parasitic	forms	are	kept	longer	time	in	
contact	with	the	active	drug	testing	solutions.	
Pyrantel	 and	 Selamectin	 have	 proven	 to	
be	 very	 effective	 against	 the	 tested	 parasites,	
also	 presenting	 minimal	 risks	 of	 resistance	
phenomena	induction.	These	active	drugs,	through	
proven	 efficacy,	 are	 recommended	 for	 use	 as	
antihelminthics	 against	 digestive	 strongylidoses	
in	 the	 studied	 dogs,	 being	 a	 good	 alternative	 in	
case	of	benzimidazole	resistance.
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